All Resources

Alberta pharmaceutical strategy : stakeholder consultation

Description

A Health Action Plan for Alberta was announced by the Minister of Health and Wellness in April 2008. A key component of this plan is the development of a pharmaceutical strategy. A consultation... More ≫

Description

A Health Action Plan for Alberta was announced by the Minister of Health and Wellness in April 2008. A key component of this plan is the development of a pharmaceutical strategy. A consultation process was implemented to meet key stakeholders, summarize their comments, and make key recommendations. Meetings were held with 16 stakeholder groups representing patients, physicians, pharmacists, employers, benefit providers, and the pharmaceutical industry. Written submissions were also welcomed. This document summarizes the stakeholders input and presents 10 recommendations for the government to implement.

Tags

Double balloon endoscopy\enteroscopy (DBE) for the diagnosis and treatment of conditions of the small intestine

Description

Double balloon endoscopy/ enteroscopy (DBE) is a non-surgical approach that provides access to the entire inner mucosal surface of the small intestine for endoscopic visual examination, biopsy and... More ≫

Description

Double balloon endoscopy/ enteroscopy (DBE) is a non-surgical approach that provides access to the entire inner mucosal surface of the small intestine for endoscopic visual examination, biopsy and treatment. DBE is being heralded as a breakthrough technology because accessing the deep small intestine endoscopically has largely been unsuccessful by conventional approaches. The purpose of this study was to to review the safety, efficacy and effectiveness of DBE and examine the potential social, fiscal and economic impact should it become a publicly funded health service in Alberta.

Tags